SciMatic
Zeitschriften
Thesis Rep
Docs
Produkte
SciMatic.net
Journament
Zeitschriftenmanager
Fächer
Abschlussarbeit
ImProofer
Forschungsgruppen
Briefbogen
Konferenzen
Dienstleistungen
Über uns
SciMatic
Blog
Team
Mit uns verdienen
Mitmachen
Kontaktieren Sie uns
DE
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Anmelden
Cancer research
Cancer Res
ISSN 1538-7445
470 views
Indexiert in
scopus
ncbi
ulakbim
sci
Publications
34
ULAKBİM
MEP: 2.993
Ödeme: 10000
Yılı: 2020
Details
Abgekürzter Name
cancer research
ISSN
1538-7445
Veröffentlichungen/Jahr
Meistgeklickte Bibliographien aus der Suche
12
Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment
2017
421 clicks
1
Erratum: Editor's note: Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Cancer Research (2005) 65 (5009–5014))
2019
378 clicks
6
Topological Tumor Graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology.
2019
355 clicks
13
A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice
1985
337 clicks
18
Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor
2004
326 clicks
7
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.
2019
314 clicks
15
A human prostatic epithelial model of hormonal carcinogenesis
2001
313 clicks
8
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.
2016
301 clicks
9
Use of natural language processing to extract clinical cancer phenotypes from electronic medical records
2019
290 clicks
2
Connecting students with patients and survivors to enhance cancer research training
2019
280 clicks
×
SciMatic auf Ihrem Handy
Verfolgen Sie Ihre Artikel, sehen Sie Zertifikate ein und bleiben Sie auf dem Laufenden — jederzeit und überall.
Google Play